🔍
So far, December has seen a bit of volatility across several microcap stocks that we actively follow. For example, the MSMqi has declined by approximately 6.25% from record highs reached in November...
Geoinvesting has launched a few Model Portfolios since 2016. However, we have been tweaking the Model Portfolio framework over the past few months. The latest is the Open Forum Focus Model Portfolio...
As we continue to adjust to the evolving market landscape and subscriber feedback, we believe it is prudent to focus on more impactful investment strategies through a main high-conviction portfolio...
As part of our ongoing series on multibagger Case Studies, private investor and GeoInvesting contributor Thomas Birnie was kind enough to offer up his second video explaining more on the dynamics of...
Overall, it was a slow week for news in our coverage universe. However, few earnings crossed the wire, but we’re particularly paying attention to one, which currently resides in our Run to $1 Model...
Understanding the anatomy of a multibagger stock—one that multiplies its initial investment value several times over, defined as gaining 100% or more—can be transformative for investors. Multibaggers...
Now, onto another spotlight—replays of MS Microcap’s second installment of The Starting 5 Virtual Conference held on November, 13, 2024 and hosted by MS Cliff Notes. So, we’ll get right into the...
The biggest hurdle for early-stage growth companies, from an investment perspective, isn’t simply determining whether they have a good business model. It’s assessing whether they can grow that...
When we introduced the concept of "You Make The Call", we explained our motivation like this. In case you missed that email here’s what these events are all about.
This event format is on an...
Run to $1.00 model portfolio remains in focus We’ve been discussing our Run to $1.00 (R21) Model Portfolio a lot lately. If you missed it, here are a few key stats featured in our October 20, 2024...
This Med-tech company’s turnaround is driven by operational restructuring, a focus on higher-margin U.S. markets, and a patient-first approach under its new CEO; The company has reported two...
Today, I want to address a comment made by a personality on X with a large following and a subscription service of his own, albeit not in investing. I like to give credence to the fact that investing...
🔍
No posts found.
Load More
—
